. 2009 Jun 6;8(4):391–397. doi: 10.1007/s10689-009-9252-x

Table 4.

Results of surveillance tools and interventions

Surveillance tool or diagnostic intervention	Number of patients		Outcome
TVU	285	240	Normal
		23	Ovarian abnormality → cyst	12 additional consults → 8 surgeries: 1 → ovarian carcinoma ^a 1 → mature teratoma 1 → borderline malignancy 5 → normal ovaries
		22	Endometrial abnormality 12 → endometrial thickness increased 5 → polyp 5 → myoma	→ Microcurettage/hysteroscopy with biopsy or curettage
CA 125 (U/ml)	270	265	≤35
CA 125 (U/ml)		5	>35	→ 316 → also enlarged ovary → ovarian carcinoma ^a → 162,6 → also enlarged ovary → exploration: borderline malignancy → 81 → repeat of measurement: same outcome → exploration → normal anatomy → 42,4 → exploration → normal anatomy → 51,0 → exploration → normal anatomy
Microcurettage/curettage/biopsy taken as routine (after January 2006)	64	49	Normal
		11	Inadequate material	Further analysis as possible^b
		4	Abnormal	3 → hyperplasia with atypia 1 → endometrial carcinoma
Microcurettage/curettage/biopsy taken after complaints or abnormal TVU (before Jan 2006)	32	24	Normal
		5	Inadequate material	Further analysis as possible^b
		3	Abnormal	1 → hyperplasia with atypia 2 → endometrial carcinoma

^aSame patient with ovarian cancer: enlarged ovary and elevated CA 125

^bReturn to surveillance for in total two patients without final pathological diagnosis, but low clinical suspicion